Cargando…

Physical function measurement in older long-term cancer survivors

OBJECTIVE: To establish reliability, validity, and minimal detectable change in measures of function in older long-term cancer survivors. METHODS: Older cancer survivors were recruited to perform functional measures; 5 Times Sit-to-Stand (5xSTS), 30-second Timed Chair Rise (30sTCR), Short Physical P...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackwood, Jennifer, Rybicki, Kateri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: HYLONOME PUBLICATIONS 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419850/
https://www.ncbi.nlm.nih.gov/pubmed/34557613
http://dx.doi.org/10.22540/JFSF-06-139
_version_ 1783748840661188608
author Blackwood, Jennifer
Rybicki, Kateri
author_facet Blackwood, Jennifer
Rybicki, Kateri
author_sort Blackwood, Jennifer
collection PubMed
description OBJECTIVE: To establish reliability, validity, and minimal detectable change in measures of function in older long-term cancer survivors. METHODS: Older cancer survivors were recruited to perform functional measures; 5 Times Sit-to-Stand (5xSTS), 30-second Timed Chair Rise (30sTCR), Short Physical Performance Battery (SPPB), Physical Performance Test-7 (PPT-7). Two testing sessions were completed two weeks apart. Test-retest reliability was examined using the intraclass correlation coefficient (ICC(2,1)), convergent and discriminant validity using Spearman’s rho and Minimal Detectable Change (MDC(95)) was calculated. RESULTS: Forty-seven older long-term cancer survivors participated. Test-retest reliability was good for 5xSTS (ICC(2,1)=0.86), 30sTCR (ICC(2,1)=0.89), and SPPB (ICC(2,1)=0.85) and poor for PPT-7 (ICC(2,1)=0.48). Both convergent and discriminant validity was established. CONCLUSIONS: SPPB, 5xSTS, and 30sTCR are reliable and valid tools to measure function in older long-term cancer survivors. MDC(95) values were larger than those reported in geriatrics and should be interpreted with caution. Residual effects of cancer treatment, comorbidity, and physical inactivity may contribute to decreased physical function in older long-term cancer survivors, therefore valid and reliable measures like SPPB and the timed chair rise tests should be used objectively measure function throughout the survivorship spectrum.
format Online
Article
Text
id pubmed-8419850
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher HYLONOME PUBLICATIONS
record_format MEDLINE/PubMed
spelling pubmed-84198502021-09-22 Physical function measurement in older long-term cancer survivors Blackwood, Jennifer Rybicki, Kateri J Frailty Sarcopenia Falls Original Article OBJECTIVE: To establish reliability, validity, and minimal detectable change in measures of function in older long-term cancer survivors. METHODS: Older cancer survivors were recruited to perform functional measures; 5 Times Sit-to-Stand (5xSTS), 30-second Timed Chair Rise (30sTCR), Short Physical Performance Battery (SPPB), Physical Performance Test-7 (PPT-7). Two testing sessions were completed two weeks apart. Test-retest reliability was examined using the intraclass correlation coefficient (ICC(2,1)), convergent and discriminant validity using Spearman’s rho and Minimal Detectable Change (MDC(95)) was calculated. RESULTS: Forty-seven older long-term cancer survivors participated. Test-retest reliability was good for 5xSTS (ICC(2,1)=0.86), 30sTCR (ICC(2,1)=0.89), and SPPB (ICC(2,1)=0.85) and poor for PPT-7 (ICC(2,1)=0.48). Both convergent and discriminant validity was established. CONCLUSIONS: SPPB, 5xSTS, and 30sTCR are reliable and valid tools to measure function in older long-term cancer survivors. MDC(95) values were larger than those reported in geriatrics and should be interpreted with caution. Residual effects of cancer treatment, comorbidity, and physical inactivity may contribute to decreased physical function in older long-term cancer survivors, therefore valid and reliable measures like SPPB and the timed chair rise tests should be used objectively measure function throughout the survivorship spectrum. HYLONOME PUBLICATIONS 2021-09-01 /pmc/articles/PMC8419850/ /pubmed/34557613 http://dx.doi.org/10.22540/JFSF-06-139 Text en Copyright: © 2021 Hylonome Publications https://creativecommons.org/licenses/by-nc-sa/4.0/All published work is licensed under Creative Commons Attribution NonCommercial - ShareAlike 4.0 International
spellingShingle Original Article
Blackwood, Jennifer
Rybicki, Kateri
Physical function measurement in older long-term cancer survivors
title Physical function measurement in older long-term cancer survivors
title_full Physical function measurement in older long-term cancer survivors
title_fullStr Physical function measurement in older long-term cancer survivors
title_full_unstemmed Physical function measurement in older long-term cancer survivors
title_short Physical function measurement in older long-term cancer survivors
title_sort physical function measurement in older long-term cancer survivors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419850/
https://www.ncbi.nlm.nih.gov/pubmed/34557613
http://dx.doi.org/10.22540/JFSF-06-139
work_keys_str_mv AT blackwoodjennifer physicalfunctionmeasurementinolderlongtermcancersurvivors
AT rybickikateri physicalfunctionmeasurementinolderlongtermcancersurvivors